Compare KRT & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRT | ACHV |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 683.8M | 618.0M |
| IPO Year | 2019 | 2018 |
| Metric | KRT | ACHV |
|---|---|---|
| Price | $34.72 | $6.48 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $26.50 | $14.67 |
| AVG Volume (30 Days) | 133.4K | ★ 2.7M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | ★ 6.33% | N/A |
| EPS Growth | ★ 4.70 | N/A |
| EPS | ★ 0.34 | N/A |
| Revenue | ★ $467,743,000.00 | N/A |
| Revenue This Year | $13.05 | N/A |
| Revenue Next Year | $8.11 | N/A |
| P/E Ratio | $100.74 | ★ N/A |
| Revenue Growth | ★ 10.67 | N/A |
| 52 Week Low | $20.61 | $2.38 |
| 52 Week High | $34.50 | $7.11 |
| Indicator | KRT | ACHV |
|---|---|---|
| Relative Strength Index (RSI) | 80.57 | 66.69 |
| Support Level | $21.64 | $4.09 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.96 | 0.47 |
| MACD | 0.46 | 0.10 |
| Stochastic Oscillator | 98.37 | 71.83 |
Karat Packaging Inc is a distributor and manufacturer of disposable foodservice products and related items, including containers, bags, tableware, cups, lids, cutlery, straws, specialty beverage ingredients, gloves, and janitorial supplies, available in plastic, paper, biopolymer-based, and other compostable forms. The Company focuses on environmentally friendly products and provides customized solutions including product development, design, printing, and logistics services. It serves customers through chains and distributors, retail, and e-commerce/online, and operates in the manufacturing and distribution of single-use food and beverage products, as well as specialty food and beverage products and restaurant and warehouse supplies.
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.